Skip to main content
OpenTrials
Completed

NCT Number: NCT00477763

Oasys vs. Extreme H20 Xtra 59

To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye contact lens pts who receive Restasis in 1 eye and vehicle (Endura) in the other eye.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hazleton Eye Specialists

Hazleton, Pennsylvania, 18202, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or Female at least 19 years of age
  • Contact Lens Wearers
  • Patients with mild to moderate symptoms of dry eye

Exclusion criteria

  • male or female younger than 19 years of age

Treatment and study plan

Restasis, Refresh Endura

Drug
  • Restasis 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening
  • Refresh Endura 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening

Primary outcomes

  1. comparing performance of contact lens

    Time frame: 10 months

Secondary outcomes

  1. Dry eye

    Time frame: 10 months

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
May 24, 2007
Registry last updated
Feb 18, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.